Did you know that stem cells are currently being used for macular degeneration treatment?
However, these stem cells are not embryonic, but rather autologous.
There are many sources of stem cells, but one common source that is used for many cancer patients needing bone marrow transplants, is a patient’s own bone marrow. These immature stem cells have the ability to develop into other specialized cells.
The X-Cell Center in Germany is one such center. In the United States, Dr. Edward Kondrot in Cave Creek, Arizona has begun using stem cell therapy as well.
On January 3, 2011, Advanced Cell Technology announced that the United States FDA approved their application to treatdry age-related macular degeneration (AMD)using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells.
Sites currently under consideration are the Jules Stein Eye Institute at UCLA, and the Ophthalmology Department at Stanford University School of Medicine.